60%+ returns in 2025: Here’s how AI-powered stock investing has changed the game
LONDON - Oxford Instruments plc expects stable full-year performance after experiencing a challenging first half impacted by global tariff disruption, according to a trading update issued Monday.
The scientific technology provider reported first-half order intake up just over 1% on an organic constant currency basis compared to the prior year, with a recovery from a 3% decline in Q1 to nearly 6% growth in Q2.
The company's two divisions showed contrasting performance. The Imaging and Analysis division saw order intake fall 11% in Q1 before stabilizing in Q2, while the Advanced Technologies division delivered strong growth of 25% in Q1 and 26% in Q2, driven by demand in compound semiconductor markets.
First-half revenues are expected to be down approximately 8% on an organic constant currency basis (10% on a reported basis), with adjusted operating profit margin around 14.5%.
"The start of our financial year coincided with the beginning of a turbulent time in our markets," said CEO Richard Tyson. "I am proud of our team's proactive and customer-focused approach to this very dynamic global trading landscape, driving an improving picture in Q2."
The company has implemented cost-saving measures at its Belfast imaging business, including workforce reductions and portfolio refocusing, which are expected to improve margins in the second half.
Oxford Instruments now forecasts full-year revenue, adjusted operating profit, and profit margin to be similar to the previous year on an organic constant currency basis. The company also anticipates an additional £1 million currency headwind to operating profit beyond earlier guidance of £4.5 million.
The previously announced sale of the NanoScience business is progressing as planned and expected to complete during Q3.
Oxford Instruments plans to announce its interim results on November 11, 2025, according to the trading update statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.